azacitidine and Pancytopenia

azacitidine has been researched along with Pancytopenia in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.69)	18.2507
2000's	0 (0.00)	29.6817
2010's	10 (76.92)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Itani, K; Kai, Y; Kohno, K; Kondo, Y; Matsumoto, M; Miura, G; Nakayama, T; Saburi, M; Soga, Y	1
Dasanu, CA; Kaur, J; Tuler, S	1
Angelopoulou, MK; Chatzidimitriou, C; Konstantopoulos, K; Korkolopoulou, P; Lafioniatis, S; Lakiotaki, E; Pappa, V; Plata, E; Vassilakopoulos, TP	1
Cao, YB; DA, WM; Li, SW; Li, XH; Liu, B; Liu, ZY; Wu, XX; Wu, YM; Xu, LX; Yan, B; Yang, XL	1
Chen, YH; Ding, Y; Liang, AB; Luo, X; Wu, H	1
Fang, LW; Hu, NB; Li, B; Luo, XP; Pan, LJ; Qin, TJ; Qu, SQ; Xiao, ZJ; Xu, ZF; Zhang, HL; Zhang, Y	1
Steensma, DP; Stone, RM	1
Ahsanuddin, A; Kumar, R; Paulson, K; Seftel, MD	1
Klimek, VM; Tallman, MS	1
Delgado, RG; Diez Campelo, M; Molias, AC; Sanchez, JF	1
Angelillo-Scherrer, A; Blum, S	1
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R	1
Huijgens, PC; Krulder, JW; Neve, P; Wijermans, PW	1

Reviews

1 review(s) available for azacitidine and Pancytopenia

Article	Year
Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes. Hematology/oncology clinics of North America, 2010, Volume: 24, Issue:2 Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Azacitidine; Clinical Trials as Topic; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Administration Schedule; Enzyme Inhibitors; Epigenesis, Genetic; Fatigue; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Mucositis; Myelodysplastic Syndromes; Pancytopenia; Patient Selection	2010

Article

Year

Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.

Hematology/oncology clinics of North America, 2010, Volume: 24, Issue:2

Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Azacitidine; Clinical Trials as Topic; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Administration Schedule; Enzyme Inhibitors; Epigenesis, Genetic; Fatigue; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Mucositis; Myelodysplastic Syndromes; Pancytopenia; Patient Selection

2010

Other Studies

12 other study(ies) available for azacitidine and Pancytopenia

Article	Year
[Successful treatment of myelodysplastic syndrome-associated autoinflammatory lymphedema with azacytidine]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:12 Topics: Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Lymphedema; Myelodysplastic Syndromes; Pancytopenia	2019
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:7 Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azacitidine; Female; Humans; Myelodysplastic Syndromes; Pancytopenia	2021
Pancytopenia, eosinophilia and coagulation disorders in a patient with T-acute lymphoblastic leukemia in prolonged remission. American journal of hematology, 2021, 05-01, Volume: 96, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers, Tumor; Blood Cell Count; Bone Marrow; Cancer Survivors; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Diagnosis, Differential; Eosinophilia; Hemorrhagic Disorders; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pancytopenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Staurosporine; Tryptases	2021
[Clinical Efficacy of Decitabine Combined with CAG Regimen for Myelodysplastic Syndrome-RAEB and Refractory Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:4 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Decitabine; Granulocyte Colony-Stimulating Factor; Humans; Karyotype; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pancytopenia; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome	2015
[Clinical Efficacy Comparison of Ultralow Dose of Decitabine and Cyclosporine on Low-risk and Intermediate-risk Type 1 of Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:2 Topics: Azacitidine; Cyclosporine; Decitabine; Humans; Myelodysplastic Syndromes; Pancytopenia; Retrospective Studies; Survival Rate; Treatment Outcome	2016
[Analysis of the impact of decitabine treatment cycles on efficacy and safety in patients of myelodysplastic syndrome-refractory anemia with excess blasts]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2016, Oct-14, Volume: 37, Issue:10 Topics: Anemia, Refractory, with Excess of Blasts; Azacitidine; Blood Cell Count; China; Decitabine; Humans; Pancytopenia; Prevalence; Remission Induction; Retrospective Studies; Treatment Outcome	2016
Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia. Leukemia & lymphoma, 2011, Volume: 52, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Female; Humans; Middle Aged; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis	2011
Hypomethylating agents in acute lymphoblastic leukemia: untapped potential? Leukemia & lymphoma, 2011, Volume: 52, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Humans; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis	2011
Azacytidine for the treatment of myelodysplastic syndromes in the elderly. Advances in therapy, 2011, Volume: 28 Suppl 2 Topics: Age Factors; Aged; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Azacitidine; Blood Component Transfusion; Bone Marrow; Bone Marrow Examination; Humans; Life Expectancy; Male; Monitoring, Physiologic; Myelodysplastic Syndromes; Pancytopenia; Treatment Outcome	2011
Block of red blood cell maturation in acute erythroid leukemia. Blood, 2012, Sep-06, Volume: 120, Issue:10 Topics: Antigens, CD; Azacitidine; Blood Cell Count; Cell Differentiation; Erythroblasts; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Pancytopenia; Polycythemia Vera; Reticulocytes	2012
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7 Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole	2013
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia, 1997, Volume: 11, Issue:1 Topics: Acute Disease; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Azacitidine; Decitabine; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia	1997